Quantcast

Latest Atheroma Stories

2014-09-10 23:14:14

NuvOx Pharma has been awarded a Phase I Small Business Innovative Research contract (contract # HHSN268201400045C) for “Development of Molecular Imaging Agents and Methods to Detect High Risk Atherosclerotic Plaque” by the National Heart, Lung, and Blood Institute (NHLBI). Tucson, Arizona (PRWEB) September 10, 2014 Evan Unger, MD, President and CEO of NuvOx Pharma announced today that NuvOx Pharma has been awarded a Phase I Small Business Innovative Research contract (contract #...

2014-09-02 08:30:49

Presented in 'State of the Art and Featured Research Session' at the 2014 European Society of Cardiology Congress TSX Exchange Symbol: RVX BARCELONA, Spain and CALGARY, AB, Sept. 2, 2014 /PRNewswire/ - Resverlogix Corp. (TSX: RVX) announced today that Dr. Jan Johansson, senior vice president of medical affairs at Resverlogix delivered an oral presentation at the 2014 European Society of Cardiology (ESC) Congress in Barcelona, Spain. In his presentation, entitled: 'Effects of...

2014-07-31 17:18:15

World Heart Federation Examining the remarkably preserved mummies of five ancient cultures, the Horus mummy research team discovered atherosclerosis (narrowing of the arteries due to build up of fatty deposits) was present in humans long before we acquired modern lifestyles. In a paper published in this month's edition of Global Heart (the journal of the World Heart Federation) the Horus team describes potential causes that could have led to atherosclerosis in ancient times, the...

2014-07-30 08:32:08

Anticipate Topline Data in 6-8 months IRVINE, Calif., July 30, 2014 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001. This Phase 1b trial will be a continuation of the AHRO-001...

healthy lifestyle reverses heart disease risk
2014-07-01 05:33:20

redOrbit Staff & Wire Reports - Your Universe Online Eliminating unhealthy habits such as losing weight and kicking the cigarette habit in your 30s and 40s could potentially reverse the natural progression of coronary artery disease, according to new research appearing in the June 30 edition of the journal Circulation. According to lead investigator Bonnie Spring, a professor of preventive medicine at the Northwestern University Feinberg School of Medicine, and her colleagues,...

2014-06-10 13:56:46

American Society for Microbiology Scientists believe they have an explanation for the axiom that stress, emotional shock, or overexertion may trigger heart attacks in vulnerable people. Hormones released during these events appear to cause bacterial biofilms on arterial walls to disperse, allowing plaque deposits to rupture into the bloodstream, according to research published in published today in mBio®, the online open-access journal of the American Society for Microbiology. "Our...

2014-06-02 12:29:37

LOS ANGELES, June 2, 2014 /PRNewswire/ -- New research has discovered that a specific form of garlic, Aged Garlic Extract (AGE), significantly reduces low-attenuation plaque, also known as "soft plaque" or non-calcified plaque, within the arteries of patients with metabolic syndrome. The findings indicate that AGE may reverse heart disease, and will be presented at the 9(th) annual scientific meeting of the Society of Cardiovascular Computed Tomography to be held July 10-13, 2014 in...

2014-05-29 10:36:33

Emory Health Sciences DNA methylation critical in model of atherosclerosis Disturbed patterns of blood flow induce lasting epigenetic changes to genes in the cells that line blood vessels, and those changes contribute to atherosclerosis, researchers have found. The findings suggest why the protective effects of good blood flow patterns, which aerobic exercise promotes, can persist over time. An epigenetic change to DNA is a chemical modification that alters whether nearby genes are...

2014-05-21 08:29:20

"Most Advanced Epigenetic Drug in Clinical Development" TSX Exchange Symbol: RVX CALGARY, May 21, 2014 /CNW/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today announced that its lead compound in clinical development, RVX-208, was prominently featured in the prestigious life science publication SciBX. SciBX: Science-Business eXchange is a weekly publication that focuses on scientific acumen of Nature Publishing Group with the business intelligence of BioCentury...

ultrasound device
2014-04-25 08:20:19

Matt Shipman, North Carolina State University Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an ultrasound device that could help identify arterial plaque that is at high risk of breaking off and causing heart attack or stroke. At issue is the plaque that builds up in arteries as we age. Some types of plaque are deemed “vulnerable,” meaning that they are more likely to detach from the artery wall and cause heart...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related